Insights from 2024 ESMO Sarcoma and Rare Cancers Congress

 

Videos
07:00

Insights from 2024 ESMO Sarcoma and Rare Cancers Congress

ctDNA Analysis From INTRIGUE Study: Updated OS & Safety With Ripretinib vs. Sunitinib in Patients With Advanced GIST Previously Treated With Imatinib and Harboring KIT exon 11 + 17/18 Mutations

FEATURING Jean-Yves Blay
  • 193 views
  • April 15, 2024
  • 1
09:59

Insights from 2024 ESMO Sarcoma and Rare Cancers Congress

Lurbinectedin + Irinotecan in Pre-Treated Gastroenteropancreatic Neuroendocrine Carcinomas

FEATURING Rocio Garcia-Carbonero
  • 97 views
  • April 15, 2024